Exploiting the curative potential of adoptive T-cell therapy for cancer
Author:
Affiliation:
1. National Cancer Institute; Surgery Branch; Bethesda MD USA
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/imr.12132/fullpdf
Reference134 articles.
1. Raising the bar: the curative potential of human cancer immunotherapy;Rosenberg;Sci Transl Med,2012
2. Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much?;Fojo;Clin Cancer Res,2010
3. High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006;Klapper;Cancer,2008
4. Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines;Smith;Clin Cancer Res,2008
5. High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993;Atkins;J Clin Oncol,1999
Cited by 400 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A detailed review of immunotherapeutics with a special emphasis on hybridoma technology;American Journal of Biopharmacy and Pharmaceutical Sciences;2024-01-25
2. Neoadjuvant personalized cancer vaccines: the final frontier?;Expert Review of Vaccines;2024-01-10
3. Generation of antigen-specific mature T cells from RAG1−/−RAG2−/−B2M−/− stem cells by engineering their microenvironment;Nature Biomedical Engineering;2023-12-07
4. One infusion of engineered long-lasting and multifunctional T cells cures asthma in mice;2023-11-06
5. Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review;Systematic Reviews;2023-09-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3